The Role of the Calcium-sensing Receptor in Gastrointestinal Inflammation
Overview
Reproductive Medicine
Affiliations
The gastrointestinal (GI) tract must balance the extraction of energy and metabolic end-products from ingested nutrition and resident gut microbes and the maintenance of a symbiotic relationship with this microbiota, with the ability to mount functional immune responses to pathogenic organisms to maintain GI health. The gut epithelium is equipped with bacteria-sensing mechanisms that discriminate between pathogenic and commensal microorganisms and regulate host responses between immunity and tolerance. The epithelium also expresses numerous nutrient-sensing receptors, but their importance in the preservation of the gut microbiota and immune homeostasis remains largely unexplored. Observations that a deficiency in the extracellular calcium-sensing receptor (CaSR) using intestinal epithelium-specific receptor knockout mice resulted in diminished intestinal barrier integrity, altered composition of the gut microbiota, modified expression of intestinal pattern recognition receptors, and a skewing of local and systemic innate responses from regulatory to stimulatory, may change the way that this receptor is considered as a potential immunotherapeutic target in gut homeostasis. These findings suggest that pharmacologic CaSR activators and CaSR-based nutrients such as calcium, polyamines, phenylalanine, tryptophan, and oligo-peptides might be useful in conditioning the gut microenvironment, and thus, in the prevention and treatment of disorders such as inflammatory bowel disease (IBD), infectious enterocolitis, and other inflammatory and secretory diarrheal diseases. Here, we review the emerging roles of the CaSR in intestinal homeostasis and its therapeutic potential for gut pathology.
Xu X, Gao Y, Xiao Y, Yu Y, Huang J, Su W Front Microbiol. 2024; 15:1479779.
PMID: 39687875 PMC: 11647010. DOI: 10.3389/fmicb.2024.1479779.
Advances in calcium-sensing receptor modulation: biased signaling and therapeutic potential.
Uhlmann L, Wagner U Signal Transduct Target Ther. 2024; 9(1):362.
PMID: 39676111 PMC: 11646996. DOI: 10.1038/s41392-024-02084-9.
Olier M, Naud N, Fouche E, Tondereau V, Ahn I, Leconte N NPJ Sci Food. 2024; 8(1):43.
PMID: 38956092 PMC: 11220098. DOI: 10.1038/s41538-024-00273-y.
Sensing of luminal contents and downstream modulation of GI function.
Dontamsetti K, Pedrosa-Suarez L, Aktar R, Peiris M JGH Open. 2024; 8(5):e13083.
PMID: 38779131 PMC: 11109814. DOI: 10.1002/jgh3.13083.
Tang L, Jin S, Winesett S, Harrell J, Fraebel J, Cheng S Res Sq. 2023; .
PMID: 37961244 PMC: 10635371. DOI: 10.21203/rs.3.rs-3482753/v1.